Media center

The recent approval of Japan's first oral abortion pill is an important step towards achieving gender equality and ensuring that women exercise their right to self-determination over their bodies, including pregnancy and childbirth. IPPF believes that true gender equality requires empowering women to be fully informed and in control of their bodies, thereby expanding their choices and enabling them to determine their own futures. Dr Alvaro Bermejo, Director General of the International Planned Parenthood Federation (IPPF), underlined the importance of this landmark milestone during a visit to Japan in April. Public support through public comments for the approval shows that the social situation in Japan is changing, with increased awareness of women's lives and health, reproductive freedom and women's rights. In its guidelines, the World Health Organisation (WHO) included oral abortion pills in the Essential Medicines Core List, in line with the evidence accumulated in the past, and removed the requirement of direct supervision by health professionals for their use as these pills can be used outside healthcare facilities without compromising safety and efficacy and the abortion process can be managed using the drug without direct supervision of health professionals. IPPF urges Japan to follow these WHO guidelines, including abortion as part of women's health care, and allow women to take safe oral abortion pills at home. Guaranteeing women in its own country access to these essential medicines is also in line with Japan's strong commitment and global pledge to achieve Universal Health Coverage (UHC), ensuring that all women have access to medicines that save their health and lives, and that no one is left behind. IPPF looks forward to, and is committed to working with and supporting, Japan's future steps towards achieving a society that supports true gender equality, where women can exercise their right to self-determination over reproduction.

The Director General of the International Planned Parenthood Federation (IPPF), Dr Alvaro Bermejo, is in Australia this week for high level meetings with Australian Government Ministers and the Australian Department of Foreign Affairs and Trade (DFAT). He is joined by Ms Tomoka Fukuda, Regional Director of IPPF’s East and Southeast Asia and Oceania Region (ESEAOR) and Ms Phoebe Ryan, IPPF’s Chief of the Australia and New Zealand Office. In Australia, Dr Bermejo has been privileged to meet with Australia’s Minister for International Development and the Pacific, the Hon Pat Conroy. Together, they discussed how Australia can play a leadership role in advancing sexual and reproductive health and rights through Australia’s international development cooperation. Last week, Dr Bermejo and Ms Fukuda visited IPPF’s Member Association in Solomon Islands, the Solomon Islands Planned Parenthood Association (SIPPA). In Solomon Islands, they witnessed SIPPA’s life-saving and critical work delivering sexual and reproductive healthcare on the ground, including mobile outreach in remote communities of Malaita Province. Australia has been a long-standing and critical partner to IPPF, supporting programming to reach women, girls, and marginalized groups across the development–humanitarian continuum around the world, with a particular focus on the Asia Pacific. In December 2022, IPPF and DFAT signed a new four-year global funding agreement for 2023 to 2026, part of which includes dedicated support to programming across the Pacific. AUD 19 million is dedicated as global funding towards the delivery of IPPF’s Strategy 2028, along with a further AUD 5.7 million to support the delivery of IPPF’s Pacific Niu Vaka Strategy, Phase 2. This generous investment will enable IPPF to reach an anticipated 1.8 million people in the Pacific over the next six years with 4.2 million essential sexual and reproductive services. IPPF is proud to stand alongside our Pacific MAs as they continue to advocate for the health and rights of those most underserved and excluded, reaching communities with essential information and high quality, person-centred sexual and reproductive health care.     In 2021, IPPF reached over 72 million people around the world with more than 155 million sexual and reproductive health services and contributed to 121 policy and legislative changes in defence of SRHR. IPPF is grateful for Australia’s ongoing support in enabling this impact. IPPF’s Director General, Alvaro Bermejo shared: “IPPF are delighted to be working with the Australian Government to continue improving the sexual and reproductive health and rights (SRHR) of women and girls across the globe. We are grateful to them for helping us deliver more services and support at a time when inequalities are deepening, the opposition is growing, and humanitarian crises continue to place the lives of millions, particularly women and girls, at risk. As we look to build the future with our new strategy, continued support from global partners is crucial to achieving a world where everyone has access to sexual and reproductive healthcare. We hope DFAT’s strong global commitment will inspire other global leaders to take action.” For media enquiries, please contact Karmen Ivey on kivey@ippf.org or Phoebe Ryan on pryan@ippf.org    About the International Planned Parenthood Federation The International Planned Parenthood Federation (IPPF) is a global service provider and advocate of sexual and reproductive health and rights for all.  For 70 years, IPPF has delivered high-quality sexual and reproductive healthcare and helped advance sexual rights, especially for people with intersectional and diverse needs that are currently unmet. Our Member Associations and partners are independent organizations that are locally owned, which means the support and care they provide is informed by local expertise and context. We advocate for a world where people are provided with the information they need to make informed decisions about their sexual health and bodies. We stand up and fight for sexual and reproductive rights and against those who seek to deny people their human right to bodily autonomy and freedom. We deliver care that is rooted in rights, respect, and dignity - no matter what.